Which drugs or procedures were allowed before and during the study, whether andhow their 屋专这周祖紧仅误错use was recorded, and any other specific rules and procedures related topermitted or prohibited c波等抗样注维医争只oncomitant therapy should be described. How allowedconcomi苏致河初事设二却扩tant therapy might affect the outcome due either to drug-drug interactionor to direct effects on the study endpoints should be discussed, and how theindependent e皮措航ffects of conc办omitant and study therapies could be ascertainedshould be explained.fromGuidline 青组苗南况不肉父轮说for IndustryStructure and Content of Clinical Study Reports 查看原帖>>
